Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anesthesia
Glucose-insulin-potassium during off-pump coronary artery bypass does not reduce myocardial injury
October 25th, 2006
Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury. According to recent research from South Korea, "This randomized, double-blind, placebo-controlled study was designed to determine whether an intra-operative, intravenous infusion of glucose-insulin-potassium (GIK) could be helpful in the prevention of myocardial ischemia and in the maintenance of intra-operative cardiac performance in patients undergoing off-pump coronary artery bypass (OP-CAB) surgery." Y.H. Shim and colleagues at Yonsei University explained, "Eighty-two adults undergoing elective OP-CAB surgery were randomly...
Source: Biotech Week (2006-10-25)
|
